Recombinant adeno-associated viral vectors are deficient in provoking a DNA damage response

Journal of Virology

Volumn 82, Issue 15, 2008, Pages 7379-7387

  Fragkos, Michalis ^a   Breuleux, Madlaina ^a,d   Clément, Nathalie ^b   Beard, Peter ^a,c  

^a EPFL   (Switzerland)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^d BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; PLASMID DNA;

ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; DNA DAMAGE; DNA SEQUENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET RADIATION; VIRUS CAPSID; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

CELL LINE; DEPENDOVIRUS; DNA DAMAGE; DNA, VIRAL; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; ULTRAVIOLET RAYS; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS - 2; ATAXIA TELANGIECTASIA; MIRIDAE;

EID: 47749127769     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00358-08     Document Type: Article

References (44)

1. Berns, K. I. 1996. Parvoviridae: the viruses and their replication, p. 2173-2197. In B. N. Fields, D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott, Williams & Wilkins, Philadelphia, PA.
2. Berns, K. I., and R. M. Linden. 1995. The cryptic life style of adeno-associated virus. Bioessays 17:237-245.
3. Berthet, C., K. Raj, P. Saudan, and P. Beard. 2005. How adeno-associated virus Rep78 protein arrests cells completely in S phase. J. Virol. 102:13634-13639.
4. Burger, C., O. S. Gorbatyuk, M. J. Velardo, C. S. Peden, P. Williams, S. Zolotukhin, P. J. Reier, R. J. Mandel, and N. Muzyczka. 2004. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2 and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10:302-317.
5. Cervelli, T., J. A. Palacios, L. Zentilin, M. Mano, R. A. Schwartz, M. D. Weitzman, and M. Giacca. 2008. Processing of recombinant AAV genomes occurs in specific nuclear structures that overlap with foci of DNA-damage-response proteins. J. Cell Sci. 121:349-357.
6. Choi, V. W., D. M. McCarty, and R. J. Samulski. 2006. Host cell DNA repair pathways in adeno-associated viral genome processing. J. Virol. 80:10346-10356.
7. Choi, V. W., R. J. Samulski, and D. M. McCarty. 2005. Effects of adeno-associated virus DNA hairpin structure on recombination. J. Virol. 79:6801-6807.
8. Christensen, J., and P. Tattersall. 2002. Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system. J. Virol. 76:6518-6531.
9. D'Amours, D., and S. P. Jackson. 2002. The Mre11 complex: at the crossroads of DNA repair and checkpoint signaling. Nat. Rev. Mol. Cell. Biol. 3:317-327.
10. Emery, D. W., T. Nishino, K. Murata, M. Fragkos, and G. Stamatoyannopoulos. 2002. Hematopoietic stem cell gene therapy. Int. J. Hematol. 75:228-236.
11. Fanning, E., V. Klimovich, and A. R. Nager. 2006. A dynamic model for replication protein A (RPA) function in DNA processing pathways. Nucleic Acids Res. 34:4126-4137.
12. Fernandez-Capetillo, O., A. Lee, M. Nussenzweig, and A. Nussenzweig. 2004. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 3:959-967.
13. Flotte, T. R., and K. I. Berns. 2005. Adeno-associated virus: a ubiquitous commensal of mammals. Hum. Gene Ther. 16:401-407.
14. Francois, A., M. Guilbaud, R. Awedikian, G. Chadeuf, P. Moullier, and A. Salvetti. 2005. The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element. J. Virol. 79:11082-11094.
15. Hendrie, P. C., and D. W. Russell. 2005. Gene targeting with viral vectors. Mol. Ther. 12:9-17.
16. Hunter, L. A., and R. J. Samulski. 1992. Colocalization of adeno-associated virus rep and capsid proteins in the nuclei of infected cells. J. Virol. 66:317-324.
17. Im, D. S., and N. Muzyczka. 1989. Factors that bind to adeno-associated virus terminal repeats. J. Virol. 63:3095-3104.
18. Jurvansuu, J., M. Fragkos, C. Ingemarsdotter, and P. Beard. 2007. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling. J. Mol. Biol. 372:397-406.
19. Jurvansuu, J., K. Raj, A. Stasiak, and P. Beard. 2005. Viral transport of DNA damage that mimics a stalled replication fork. J. Virol. 79:569-580.
20. Kotin, R. M., M. Siniscalco, R. J. Samulski, X. D. Zhu, L. Hunter, C. A. Laughlin, S. McLaughlin, N. Muzyczka, M. Rocchi, and K. I. Berns. 1990. Site-specific integration by adeno-associated virus. J. Virol. 87:2211-2215.
21. Lilley, C. E., R. A. Schwartz, and M. D. Weitzman. 2007. Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 15:119-126.
22. MacDougall, C. A., T. S. Byun, C. Van, M. C. Yee, and K. A. Cimprich. 2007. The structural determinants of checkpoint activation. Genes Dev. 21:898-903.
23. McCarty, D. M., P. E. Monahan, and R. J. Samulski. 2001. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8:1248-1254.
24. McCarty, D. M., S. M. Young, Jr., and R. J. Samulski. 2004. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38:819-845.
25. Michael, W. M., R. Ott, E. Fanning, and J. Newport. 2000. Activation of the DNA replication checkpoint through RNA synthesis by primase. Science 289:2133-2137.
26. Miller, D. G., G. D. Trobridge, L. M. Petek, M. A. Jacobs, R. Kaul, and D. W. Russell. 2005. Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J. Virol. 79:11434-11442.
27. Ni, T. H., W. F. McDonald, I. Zolotukhin, T. Melendy, S. Waga, B. Stillman, and N. Muzyczka. 1998. Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection. J. Virol. 72:2777-2787.
28. Nony, P., J. Tessier, G. Chadeuf, P. Ward, A. Giraud, M. Dugast, R. M. Linden, P. Moullier, and A. Salvetti. 2001. Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. J. Virol. 75:9991-9994.
29. Nur-E-Kamal, A., T. K. Li, A. Zhang, H. Qi, E. S. Hars, and L. F. Liu. 2003. Single-stranded DNA induces ataxia telangiectasia mutant (ATM)/p53-dependent DNA damage and apoptotic signals. J. Biol. Chem. 278:12475-12481.
30. Philpott, N. J., C. Giraud-Wali, C. Dupuis, J. Gomos, H. Hamilton, K. I. Berns, and E. Falck-Pedersen. 2002. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. J. Virol. 76:5411-5421.
31. Philpott, N. J., J. Gomos, K. I. Berns, and E. Falck-Pedersen. 2002. A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc. Natl. Acad. Sci. USA 99:12381-12385.
32. Ponnazhagan, S., D. Erikson, W. G. Kearns, S. Z. Zhou, P. Nahreini, X. S. Wang, and A. Srivastava. 1997. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8:275-284.
33. Raj, K., P. Ogston, and P. Beard. 2001. Virus-mediated killing of cells that lack p53 activity. Nature 412:914-917.
34. Redon, C., D. Pilch, E. Rogakou, O. Sedelnikova, K. Newrock, and W. Bonner. 2002. Histone H2A variants H2AX and H2AZ. Curr. Opin. Genet. Dev. 12:162-169.
35. Schwartz, R. A., J. A. Palacios, G. D. Cassell, S. Adam, M. Giacca, and M. D. Weitzman. 2007. The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication. J. Virol. 81:12936-12945.
36. Stracker, T. H., G. D. Cassell, P. Ward, Y. M. Loo, B. van Breukelen, S. D. Carrington-Lawrence, R. K. Hamatake, P. C. van der Vliet, S. K. Weller, T. Melendy, and M. D. Weitzman. 2004. The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication. J. Virol. 78:441-453.
37. Tullis, G. E., and T. Shenk. 2000. Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size. J. Virol. 74:11511-11521.
38. Vihinen-Ranta, M., S. Suikkanen, and C. R. Parrish. 2004. Pathways of cell infection by parvoviruses and adeno-associated viruses. J. Virol. 78:6709-6714.
39. Wang, Z., H. I. Ma, J. Li, L. Sun, J. Zhang, and X. Xiao. 2003. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene. Ther. 10:2105-2111.
40. Ward, P., F. B. Dean, M. E. O'Donnell, and K. I. Berns. 1998. Role of the adenovirus DNA-binding protein in vitro adeno-associated virus DNA replication. J. Virol. 72:420-427.
41. Weitzman, M. D., K. J. Fisher, and J. M. Wilson. 1996. Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J. Virol. 70:1845-1854.
42. Winocour, E., M. F. Callaham, and E. Huberman. 1988. Perturbation of the cell cycle by adeno-associated virus. Virology 167:393-399.
43. Xie, Q., J. Hare, J. Turnigan, and M. S. Chapman. 2004. Large-scale production, purification and crystallization of wild-type adeno-associated virus-2. J. Virol. Methods 122:17-27.
44. Zou, Y., Y. Liu, X. Wu, and S. M. Shell. 2006. Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J. Cell Physiol. 208:267-273.